NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/06/2024
Back to search
Official data from USPTO
ACCUCAINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
02/06/2024
Trademark type
Word
Nice classes
5
Filing date
03/28/2016
Registration date
11/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2024
Last transaction
02/06/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/28/2016
First use in commerce
06/28/2016
Drawing code
4
Owner type
03
Owner location
Torrance, CA, US
Examiner
LE, KHANH M
Law office
M70
Current location
TMO LAW OFFICE 116
Holders and representatives
Holders
Asclemed USA, Inc.
Representatives
Irene Y. Lee Russ, August & Kabat
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Prescription medicines and non-prescription medicinespharmaceutical preparations in injectable liquid vials used as local anesthetic to relieve pain and swelling; and medicinal kitscomprising preparations in injectable liquid vials as local anesthetic to relieve pain and swelling
Publications
History of USPTO decisions and trademark events.
29 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/06/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/01/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
02/01/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/18/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
07/25/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/25/2023
E815
TEAS SECTION 8 & 15 RECEIVED
01/30/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/28/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/25/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/24/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/05/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/03/2017
IUAF
USE AMENDMENT FILED
09/25/2017
EISU
TEAS STATEMENT OF USE RECEIVED
09/25/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/04/2017
EX1G
SOU EXTENSION 1 GRANTED
03/31/2017
EXT1
SOU EXTENSION 1 FILED
03/31/2017
EEXT
SOU TEAS EXTENSION RECEIVED
03/31/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/18/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/11/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/16/2016
PUBO
PUBLISHED FOR OPPOSITION
08/16/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/27/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/11/2016
DOCK
ASSIGNED TO EXAMINER
07/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/31/2016
NWAP
NEW APPLICATION ENTERED
03/31/2016
Continuous trademark protection
Get notified about every new filing that threatens ACCUCAINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.